Log in to save to my catalogue

Clinical Implication of Phosphodiesterase-4-Inhibition

Clinical Implication of Phosphodiesterase-4-Inhibition

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8835523

Clinical Implication of Phosphodiesterase-4-Inhibition

About this item

Full title

Clinical Implication of Phosphodiesterase-4-Inhibition

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1209

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The pleiotropic function of 3′,5′-cyclic adenosine monophosphate (cAMP)-dependent pathways in health and disease led to the development of pharmacological phosphodiesterase inhibitors (PDE-I) to attenuate cAMP degradation. While there are many isotypes of PDE, a predominant role of PDE4 is to regulate fundamental functions, including endothelial an...

Alternative Titles

Full title

Clinical Implication of Phosphodiesterase-4-Inhibition

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8835523

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8835523

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms23031209

How to access this item